Global Oncology/Cancer Drugs Market Growth, Share, Size, Trends and Forecast (2024 - 2030)

Segmented by Drug Class Type;

Chemotherapy, Targeted Therapy, Immunotherapy (Biologic Therapy) and Hormonal Therapy.

Segmented by Indication;

Lung Cancer, Stomach Cancer, Colorectal Cancer, Breast Cancer, Prostate Cancer, Liver Cancer, Esophagus Cancer, Cervical Cancer, Kidney Cancer, Bladder Cancer and Other Cancers.

Segmented by Geography;

North America, Europe, Asia Pacific, Middle East and Africa and Latin America - Report Timeline (2020 - 2030).
Report ID: Rn192615708 Published Date: April, 2024 Updated Date: May, 2024

Introduction

Global Oncology/Cancer Drugs Market (USD Million), 2020 - 2030

*Graph shown for illustrative purpose only, the final report will have the graph with actual data and data labels
# Global Market (USD Million), 2020 - 2030
2020 60.1
2021 61.2
2022 66.4
2023 73.5
2024 80.3
2025 90.1
2026 98.7
2027 106.9
2028 114.0
2029 119.8
2030 142.5

In the year 2023, the Global Oncology/Cancer Drugs Market was valued at USD 168,323.98 million. The size of this market is expected to increase to USD 279,257.76 million by the year 2030, while growing at a Compounded Annual Growth Rate (CAGR) of 7.5%.

  1. Introduction
    1. Research Objectives and Assumptions
    2. Research Methodology
    3. Abbreviations
  2. Market Definition & Study Scope
  3. Executive Summary
    1. Market Snapshot, By Drug Class Type
    2. Market Snapshot, By Indication
    3. Market Snapshot, By Region
    4. Market Opportunity Map
  4. Global Oncology/Cancer Drugs Market Dynamics
    1. Drivers, Restraints and Opportunities
      1. Drivers
        1. Rise in incidence of cancer across the globe
        2. Surge in global geriatric population
        3. Increase in government expenditures on healthcare
      2. Restraints
        1. Adverse effects associated with the use of cancer drugs
      3. Opportunities
        1. Untapped emerging economies
        2. Increase in number of pipeline drugs
    2. Regulatory Scenario
    3. Reimbursement Scenario
    4. Mergers & Acquisitions, Collaborations & Partnerships, Agreements
    5. Pipeline Analysis/Technological Advancements
    6. PEST Analysis
      1. Political Analysis
      2. Economic Analysis
      3. Social Analysis
      4. Technological Analysis
    7. Porter's Analysis
      1. Bargaining Power of Suppliers
      2. Bragaining Power of Buyers
      3. Threat of Substitutes
      4. Threat of New Entrants
      5. Industry Rivalry
  5. Market Segmentation
    1. Global Oncology/Cancer Drugs Market, By Drug Class Type, 2022 - 2032 (USD Million)
      1. Introduction
      2. Market Share Analysis, 2024 and 2030 (%)
      3. Y-o-Y Growth Analysis, 2021 - 2030
      4. Segment Trends
        1. Chemotherapy
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
        2. Targeted Therapy
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
        3. Immunotherapy (Biologic Therapy)
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
        4. Hormonal Therapy
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
    2. Global Oncology/Cancer Drugs Market, By Indication, 2022 - 2032 (USD Million)
      1. Introduction
      2. Market Share Analysis, 2024 and 2030 (%)
      3. Y-o-Y Growth Analysis, 2021 - 2030
      4. Segment Trends
        1. Lung Cancer
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
        2. Stomach Cancer
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
        3. Colorectal Cancer
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
        4. Breast Cancer
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
        5. Prostate Cancer
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
        6. Liver Cancer
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
        7. Esophagus Cancer
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
        8. Cervical Cancer
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
        9. Kidney Cancer
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
        10. Bladder Cancer
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
        11. Other Cancers
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
    3. Global Oncology/Cancer Drugs Market, By Geography, 2022 - 2032 (USD Million)
      1. Introduction
      2. Market Share Analysis, 2024 and 2030 (%)
      3. Y-o-Y Growth Analysis, 2021 - 2030
      4. Regional Trends
        1. North America
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, By Drug Class Type, 2020 - 2030 (USD Million)
          3. Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020 - 2030 (USD Million)
            1. United States
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug Class Type, 2020 - 2030 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020 - 2030 (USD Million)
            2. Canada
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug Class Type, 2020 - 2030 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020 - 2030 (USD Million)
        2. Europe
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, By Drug Class Type, 2020 - 2030 (USD Million)
          3. Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020 - 2030 (USD Million)
            1. Germany
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug Class Type, 2020 - 2030 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020 - 2030 (USD Million)
            2. United Kingdom
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug Class Type, 2020 - 2030 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020 - 2030 (USD Million)
            3. France
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug Class Type, 2020 - 2030 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020 - 2030 (USD Million)
            4. Italy
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug Class Type, 2020 - 2030 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020 - 2030 (USD Million)
            5. Spain
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug Class Type, 2020 - 2030 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020 - 2030 (USD Million)
            6. Rest of Europe
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug Class Type, 2020 - 2030 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020 - 2030 (USD Million)
        3. Asia Pacific
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, By Drug Class Type, 2020 - 2030 (USD Million)
          3. Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020 - 2030 (USD Million)
            1. Japan
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug Class Type, 2020 - 2030 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020 - 2030 (USD Million)
            2. China
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug Class Type, 2020 - 2030 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020 - 2030 (USD Million)
            3. India
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug Class Type, 2020 - 2030 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020 - 2030 (USD Million)
            4. Australia & New Zealand
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug Class Type, 2020 - 2030 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020 - 2030 (USD Million)
            5. South Korea
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug Class Type, 2020 - 2030 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020 - 2030 (USD Million)
            6. ASEAN (Association of South East Asian Countries)
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug Class Type, 2020 - 2030 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020 - 2030 (USD Million)
            7. Rest of Asia Pacific
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug Class Type, 2020 - 2030 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020 - 2030 (USD Million)
        4. Latin America
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, By Drug Class Type, 2020 - 2030 (USD Million)
          3. Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020 - 2030 (USD Million)
            1. Brazil
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug Class Type, 2020 - 2030 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020 - 2030 (USD Million)
            2. Mexico
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug Class Type, 2020 - 2030 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020 - 2030 (USD Million)
            3. Argentina
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug Class Type, 2020 - 2030 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020 - 2030 (USD Million)
            4. Rest of Latin America
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug Class Type, 2020 - 2030 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020 - 2030 (USD Million)
        5. Middle East & Africa
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, By Drug Class Type, 2020 - 2030 (USD Million)
          3. Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020 - 2030 (USD Million)
            1. GCC
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug Class Type, 2020 - 2030 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020 - 2030 (USD Million)
            2. Israel
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug Class Type, 2020 - 2030 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020 - 2030 (USD Million)
            3. South Africa
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug Class Type, 2020 - 2030 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020 - 2030 (USD Million)
            4. Rest of Middle East & Africa
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug Class Type, 2020 - 2030 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020 - 2030 (USD Million)
  6. Competitive Landscape
    1. Heat Map Analysis
    2. Company Profiles
      1. AbbVie Inc.
        1. Company Overview and Product Portfolio
        2. Key Developments
        3. Financial Overview
        4. Strategies
        5. Company SWOT Analysis
      2. Astellas Pharma Inc.
        1. Company Overview and Product Portfolio
        2. Key Developments
        3. Financial Overview
        4. Strategies
        5. Company SWOT Analysis
      3. AstraZeneca PLC
        1. Company Overview and Product Portfolio
        2. Key Developments
        3. Financial Overview
        4. Strategies
        5. Company SWOT Analysis
      4. Bristol-Myers Squibb Company
        1. Company Overview and Product Portfolio
        2. Key Developments
        3. Financial Overview
        4. Strategies
        5. Company SWOT Analysis
      5. Celgene Corporation
        1. Company Overview and Product Portfolio
        2. Key Developments
        3. Financial Overview
        4. Strategies
        5. Company SWOT Analysis
      6. F. HOFFMANN-LA ROCHE LTD.
        1. Company Overview and Product Portfolio
        2. Key Developments
        3. Financial Overview
        4. Strategies
        5. Company SWOT Analysis
      7. JOHNSON & JOHNSON
        1. Company Overview and Product Portfolio
        2. Key Developments
        3. Financial Overview
        4. Strategies
        5. Company SWOT Analysis
      8. Merck & Co., Inc.
        1. Company Overview and Product Portfolio
        2. Key Developments
        3. Financial Overview
        4. Strategies
        5. Company SWOT Analysis
      9. Novartis AG
        1. Company Overview and Product Portfolio
        2. Key Developments
        3. Financial Overview
        4. Strategies
        5. Company SWOT Analysis
      10. Pfizer Inc.
        1. Company Overview and Product Portfolio
        2. Key Developments
        3. Financial Overview
        4. Strategies
        5. Company SWOT Analysis
  7. Analyst Views
  8. Future Outlook of the Market

ReAnIn's Most Viewed Titles:

Healthcare Medical Devices Ophthalmoscopes
Global Ophthalmoscopes Market Growth, Share, Size, Trends and Forecast (2024 - 2030)

In the year 2023, the Global Ophthalmoscopes Market was valued at USD xx.x million. The size of this market is expected to increase to USD xx.x million by the year 2030, while growing at a Compounded Annual Growth Rate (CAGR) of x.x%

Single User License $4200 Read More ...
Healthcare Healthcare IT Operating Room Management
Global Operating Room Management Market Growth, Share, Size, Trends and Forecast (2024 - 2030)

In the year 2023, the Global Operating Room Management Market was valued at USD xx.x million. The size of this market is expected to increase to USD xx.x million by the year 2030, while growing at a Compounded Annual Growth Rate (CAGR) of x.x%

Single User License $4200 Read More ...
Healthcare Medical Devices Ophthalmic Refractometer
Global Ophthalmic Refractometer Market Growth, Share, Size, Trends and Forecast (2024 - 2030)

In the year 2023, the Global Ophthalmic Refractometer Market was valued at USD xx.x million. The size of this market is expected to increase to USD xx.x million by the year 2030, while growing at a Compounded Annual Growth Rate (CAGR) of x.x%

Single User License $4200 Read More ...
Healthcare Medical Devices Ophthalmic Viscosurgical Devices (OVD)
Global Ophthalmic Viscosurgical Devices (OVD) Market Growth, Share, Size, Trends and Forecast (2024 - 2030)

In the year 2023, the Global Ophthalmic Viscosurgical Devices (OVD) Market was valued at USD xx.x million. The size of this market is expected to increase to USD xx.x million by the year 2030, while growing at a Compounded Annual Growth Rate (CAGR) of x.x%

Single User License $4200 Read More ...